BDBM50013202 3-[(5-Chloro-pyrazin-2-ylamino)-methyl]-5-(2-fluoro-phenyl)-1,3-dihydro-benzo[e][1,4]diazepin-2-one::CHEMBL423918

SMILES Fc1ccccc1C1=NC(CNc2cnc(Cl)cn2)C(=O)Nc2ccccc12

InChI Key InChIKey=PKPCNUPLPQWEMV-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 50013202   

TargetGastrin/cholecystokinin type B receptor(Homo sapiens (Human))
Merck Sharp & Dohme Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50013202(3-[(5-Chloro-pyrazin-2-ylamino)-methyl]-5-(2-fluor...)
Affinity DataIC50:  1.00E+5nMAssay Description:Inhibition of binding of [125I]-CCK-8 to Cholecystokinin type B receptor in guinea pig brain tissuesMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCholecystokinin receptor type A(RAT)
Merck Sharp & Dohme Research Laboratories

Curated by ChEMBL
LigandPNGBDBM50013202(3-[(5-Chloro-pyrazin-2-ylamino)-methyl]-5-(2-fluor...)
Affinity DataIC50:  1.50E+4nMAssay Description:Inhibition of binding of [125I]-CCK-8 to Cholecystokinin type A receptor in rat pancreasMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed